FILE PHOTO: Logos of Pfizer at the company’s booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, 2025.REUTERS/Maxim Shemetov/File Photo (Reuters) -Mikael Dolsten, ...

Novo Nordisk said that Mikael Dolsten has decided to pull out from his proposed appointment to the company's board of directors for personal reasons. The Danish drugmaker is holding a special ...

On Friday, Novo Nordisk A/S' (NYSE: NVO) board director Mikael Dolsten said he will not seek election to the Board of Directors at the upcoming extraordinary general meeting on 14 November 2025.

(Reuters) -Mikael Dolsten, Pfizer's former research and development chief, has withdrawn his candidacy for Novo Nordisk's board, citing personal reasons, the Danish drugmaker said on Thursday. Dolsten ...